Physician

David C Wang

According to 2025 Medicare claims, David Wang (NPI: 1649491440) practices cardiac electrophysiology in the Provo-Orem-Lehi, UT market, with the plurality of this provider's patient population coming from Utah, UT. This provider's primary affiliated billing organization is REVERE HEALTH PC (NPI: 1093764805; TIN: 870281028) and primary practice location at 84604-3305. Wang is affiliated with the Aledade 201 National MSSP (ACO ID: A5522) and Revere Health Collaborative Network, LLC (ACO ID: D0042), participating under both the MSSP and REACH models.

Wang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,219 traditional Medicare patients, billed 7,550 HCPCS/CPT codes, and received $418,448 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,164 prescription claims across 1,113 beneficiaries totaling $1,598,157 in drug costs, led by Eliquis (Apixaban). DME data shows 26 claims. Open Payments data shows 42 records totaling $922. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $430,972 to $1,598,157. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $30,471 to $1,167.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,443	5,074	$393,302
2016	1,589	4,878	$368,551
2017	1,613	4,989	$370,281
2018	1,709	4,814	$317,500
2019	1,515	5,221	$433,296
2020	1,207	5,157	$341,643
2021	1,104	5,272	$362,994
2022	1,150	5,134	$363,430
2023	1,225	5,304	$368,051
2024	1,219	7,550	$418,448

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	818	5,234	$430,972
2016	850	5,931	$553,457
2017	949	6,499	$735,918
2018	1,002	6,417	$940,081
2019	1,052	6,705	$1,104,905
2020	1,029	6,328	$1,246,135
2021	970	5,370	$1,280,649
2022	946	4,821	$1,310,678
2023	1,032	4,890	$1,408,385
2024	1,113	5,164	$1,598,157

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	22	208	$22,190
2016	12	182	$10,713
2017	N/R	84	$3,359
2018	N/R	60	$2,878
2019	N/R	31	$2,077
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	26	$1,167

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	791	1,021	$89
93280	Programming of dual lead pacemaker system	296	362	$56
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	494	1,363	$20
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	606	1,694	$14
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	769	1,012	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	1,052	61,434	$1,159,124
Xarelto	Rivaroxaban	317	18,684	$341,178
Flecainide Acetate	Flecainide Acetate	752	59,180	$27,704
Sotalol	Sotalol Hcl	974	75,925	$19,721
Amiodarone Hcl	Amiodarone Hcl	326	23,405	$7,977

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	13	$957
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	13	$211

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	42	$922	Biosense Webster, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David C. Wang?

Tedicare shows public-source Medicare data for David C. Wang (NPI 1649491440), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David C. Wang have ACO affiliation data?

David C. Wang is shown with ACO affiliation data for Aledade 201 National MSSP (MSSP, ACO ID A5522) and Revere Health Collaborative Network, LLC (REACH, ACO ID D0042).

What billing organization is linked to David C. Wang?

David C. Wang is linked to REVERE HEALTH PC (billing NPI 1093764805) in the available physician profile data.

Does David C. Wang have Open Payments data?

David C. Wang has 42 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.